• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双层漂浮胶囊:一种用于米索前列醇的胃靶向给药系统。

The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol.

作者信息

Oth M, Franz M, Timmermans J, Möes A

机构信息

Searle European Development Centre, Mont-Saint-Guibert, Belgium.

出版信息

Pharm Res. 1992 Mar;9(3):298-302. doi: 10.1023/a:1015870314340.

DOI:10.1023/a:1015870314340
PMID:1614959
Abstract

A bilayer floating dosage unit is proposed to achieve local delivery of misoprostol, a prostaglandin E1 analogue, at the gastric mucosa level. The system is a capsule consisting of a floating layer maintaining the dosage unit buoyant upon the gastric content and a drug layer formulated to act as a sustained-delivery system. The differential design of the two layers allows the optimization of both floating capability and drug release profile. The layers are both composed of a hydrophilic matrix based upon hydroxypropylmethyl cellulose (HPMC). Parameters influencing the release profiles are described. The use of a large capsule increases the gastric residence time (GRT), as it impedes passage through the pylorus opening. gamma-Scintigraphic studies were performed to visualize cohesion of the two layers in vivo and to determine GRT as a function of meal regimen. The average GRTs were 199 +/- 69 min after a single meal (breakfast) and 618 +/- 208 min after a succession of meals.

摘要

提出了一种双层漂浮剂型单位,以实现在胃黏膜水平局部递送米索前列醇(一种前列腺素E1类似物)。该系统是一种胶囊,由使剂型单位在胃内容物上保持漂浮的漂浮层和配制为持续释放系统的药物层组成。两层的差异设计允许优化漂浮能力和药物释放曲线。两层均由基于羟丙基甲基纤维素(HPMC)的亲水性基质组成。描述了影响释放曲线的参数。使用大胶囊会增加胃滞留时间(GRT),因为它会阻碍通过幽门开口。进行了γ闪烁扫描研究,以在体内观察两层的黏附情况,并确定GRT作为进餐方案的函数。单次进餐(早餐)后的平均GRT为199±69分钟,连续进餐之后为618±208分钟。

相似文献

1
The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol.双层漂浮胶囊:一种用于米索前列醇的胃靶向给药系统。
Pharm Res. 1992 Mar;9(3):298-302. doi: 10.1023/a:1015870314340.
2
Gastroretentive dosage forms.胃滞留剂型
Crit Rev Ther Drug Carrier Syst. 1993;10(2):143-95.
3
Intragastric behavior and absorption kinetics of a normal and "floating" modified-release capsule of isradipine under fasted and fed conditions.空腹和进食条件下伊拉地平普通型与“漂浮型”缓释胶囊的胃内行为及吸收动力学
J Pharm Sci. 1988 Aug;77(8):647-57. doi: 10.1002/jps.2600770802.
4
Catalytic functionalization of polymers: a novel approach to site specific delivery of misoprostol to the stomach.聚合物的催化功能化:一种将米索前列醇特异性输送至胃部的新方法。
J Med Chem. 1993 Oct 15;36(21):3087-97. doi: 10.1021/jm00073a007.
5
Investigating the prilling/vibration technique to produce gastric-directed drug delivery systems for misoprostol.研究造粒/振动技术生产米索前列醇胃靶向给药系统。
Int J Pharm. 2024 Feb 15;651:123762. doi: 10.1016/j.ijpharm.2023.123762. Epub 2024 Jan 5.
6
Floating dosage forms: an in vivo study demonstrating prolonged gastric retention.漂浮剂型:一项证明胃内滞留时间延长的体内研究。
J Control Release. 1998 Oct 30;55(1):3-12. doi: 10.1016/s0168-3659(97)00266-6.
7
Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy.控制漂浮型骨架胶囊浮力和胃滞留能力的因素:重新审视争议的新数据
J Pharm Sci. 1994 Jan;83(1):18-24. doi: 10.1002/jps.2600830106.
8
Formulation and evaluation of novel coated floating tablets of bergenin and cetirizine dihydrochloride for gastric delivery.新型没食子酰基橙皮苷和盐酸西替利嗪包衣漂浮片的配方与评价及其胃部给药研究。
Drug Dev Ind Pharm. 2012 Oct;38(10):1280-8. doi: 10.3109/03639045.2011.645836. Epub 2011 Dec 30.
9
Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique.采用一种新的 MRI 标记技术对漂浮和下沉型抗酸胶囊的胃肠道转运和崩解行为进行表征。
Eur J Pharm Sci. 2019 Mar 1;129:163-172. doi: 10.1016/j.ejps.2019.01.012. Epub 2019 Jan 10.
10
Design and gamma-scintigraphic evaluation of a floating and pulsatile drug delivery system based on an impermeable cylinder.基于不透水圆柱体的漂浮脉动给药系统的设计与γ闪烁成像评估
Chem Pharm Bull (Tokyo). 2007 Apr;55(4):580-5. doi: 10.1248/cpb.55.580.

引用本文的文献

1
Formulation of a Gastroretentive In Situ Oral Gel Containing Metformin HCl Based on DoE.基于实验设计法的含盐酸二甲双胍胃滞留原位口服凝胶的制剂研发
Pharmaceutics. 2022 Aug 25;14(9):1777. doi: 10.3390/pharmaceutics14091777.
2
The Development of Innovative Dosage Forms of the Fixed-Dose Combination of Active Pharmaceutical Ingredients.活性药物成分固定剂量组合的创新剂型研发
Pharmaceutics. 2022 Apr 11;14(4):834. doi: 10.3390/pharmaceutics14040834.
3
Gastroretentive Technologies in Tandem with Controlled-Release Strategies: A Potent Answer to Oral Drug Bioavailability and Patient Compliance Implications.

本文引用的文献

1
Influence of meal weight and caloric content on gastric emptying of meals in man.餐量和热量对人体进餐时胃排空的影响。
Dig Dis Sci. 1984 Jun;29(6):513-9. doi: 10.1007/BF01296271.
2
Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition.人体中海德堡胶囊胃内停留时间的估计:不同食物成分的影响
Gastroenterology. 1985 Aug;89(2):392-7. doi: 10.1016/0016-5085(85)90342-7.
3
The hydrodynamically balanced system: a novel principle of controlled drug release.流体动力学平衡系统:一种新型的控释原理。
胃滞留技术与控释策略相结合:解决口服药物生物利用度和患者依从性问题的有效方案。
Pharmaceutics. 2021 Sep 30;13(10):1591. doi: 10.3390/pharmaceutics13101591.
4
Highlighting the impact of chitosan on the development of gastroretentive drug delivery systems.强调壳聚糖对胃滞留型药物传递系统发展的影响。
Int J Biol Macromol. 2020 Sep 15;159:804-822. doi: 10.1016/j.ijbiomac.2020.05.104. Epub 2020 May 18.
5
In-vitro and in-vivo evaluation of repaglinide loaded floating microspheres prepared from different viscosity grades of HPMC polymer.不同黏度级别的 HPMC 聚合物制备的瑞格列奈载药漂浮微球的体外和体内评价。
Saudi Pharm J. 2015 Nov;23(6):675-82. doi: 10.1016/j.jsps.2015.02.013. Epub 2015 Feb 27.
6
Influence of different types of low substituted hydroxypropyl cellulose on tableting, disintegration, and floating behaviour of floating drug delivery systems.不同类型低取代羟丙基纤维素对漂浮型药物给药系统的片剂成型、崩解和漂浮行为的影响。
Saudi Pharm J. 2015 Nov;23(6):658-66. doi: 10.1016/j.jsps.2014.09.001. Epub 2014 Oct 7.
7
Ethyl cellulose and hydroxypropyl methyl cellulose buoyant microspheres of metoprolol succinate: Influence of pH modifiers.琥珀酸美托洛尔的乙基纤维素和羟丙基甲基纤维素漂浮微球:pH调节剂的影响。
Int J Pharm Investig. 2013 Jul;3(3):163-70. doi: 10.4103/2230-973X.119235.
8
In-vitro characterization of gastroretentive microballoons prepared by the emulsion solvent diffusion method.通过乳液溶剂扩散法制备的胃滞留微球的体外特性研究
J Adv Pharm Technol Res. 2010 Jan;1(1):56-67.
9
Preparation and in vitro Characterization of Porous Carrier-Based Glipizide Floating Microspheres for Gastric Delivery.用于胃部给药的基于多孔载体的格列吡嗪漂浮微球的制备及体外表征
J Young Pharm. 2011 Apr;3(2):97-104. doi: 10.4103/0975-1483.80292.
10
Floating drug delivery systems: a review.漂浮药物递送系统:综述
AAPS PharmSciTech. 2005 Oct 19;6(3):E372-90. doi: 10.1208/pt060347.
Eur Neurol. 1987;27 Suppl 1:21-7. doi: 10.1159/000116171.
4
Effects of gender, posture, and age on gastric residence time of an indigestible solid: pharmaceutical considerations.性别、姿势和年龄对难消化固体胃内滞留时间的影响:药学考量
Pharm Res. 1988 Oct;5(10):639-44. doi: 10.1023/a:1015922903843.
5
Hydrodynamically balanced systems as sustained release dosage forms for propranolol hydrochloride.作为盐酸普萘洛尔缓释剂型的流体动力学平衡系统
Pharmazie. 1990 May;45(5):356-8.
6
Gastric delivery system for iron supplementation.用于补铁的胃内给药系统。
Lancet. 1990 May 12;335(8698):1136-9. doi: 10.1016/0140-6736(90)91135-w.